4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-014468
EVP & Chief Technology Officer sold 2,711 shares at $10.05 ($27,251)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HANLY ANN M. EVP & Chief Technology Officer | 2024-04-01 | Sale 10b5-1 | −2,711 | $10.05 | $27,251 | 132,069 | D |
| Open-market sales · 2,711 sh · avg $10.05 · $27,251 | |||||||
Loading xslF345X05/wk-form4_1712105892.xml…